hydroquinone has been researched along with Albinism, Oculocutaneous in 1 studies
Albinism, Oculocutaneous: Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chawla, S | 1 |
| Kvalnes, K | 1 |
| deLong, MA | 1 |
| Wickett, R | 1 |
| Manga, P | 1 |
| Boissy, RE | 1 |
1 other study available for hydroquinone and Albinism, Oculocutaneous
| Article | Year |
|---|---|
DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis.
Topics: Albinism, Oculocutaneous; Animals; Antioxidants; Apoptosis; Arbutin; Catalase; Cell Proliferation; C | 2012 |